Remove practice-management law-and-regulations
article thumbnail

Opinion: STAT+: Medical devices makers are trying to take a page from Uber’s playbook

STAT

Device makers face myriad obstacles, including traditional practice patterns and consumer behavior, existing economic relationships and dependencies, and, in some cases, regulatory barriers. In a recent survey of U.S. The latter, while designed to ensure safety and effectiveness, often serve to solidify the market dominance of incumbents.

117
117
article thumbnail

Florida’s Prescription Drug Reform Act: What it Means for Florida Pharmacies

Digital Pharmacist

The Prescription Drug Reform Act aims to regulate pharmacy benefit managers (PBMs) and pharmaceutical manufacturers in the state. Through these provisions, PBM questionable practices are addressed and benefits are provided to pharmacies. To note, the Office of Insurance Regulation (OIR) will oversee PBM conduct in Florida.

Insurance 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ACI To Host Multiple Events Featuring HP&M Speakers – Discounts Available to FDA Law Blog Readers

The FDA Law Blog

John counsels FDA-regulated entities on litigation, enforcement, and compliance matters including FDA inspections, Form 483s, Warning and Untitled Letters and Consent Decrees, internal investigations, and data privacy concerns. FDA Law Blog readers can use discount code S10-866-866L24.S On March 20-21, Counsel John W.M.

FDA 59
article thumbnail

Hyman, Phelps & McNamara, P.C. Takes Top Honors in Two Prestigious Categories in 2023 LMG Life Sciences Awards

The FDA Law Blog

The LMG awards are reflective of HPM’s excellence across several of our core life sciences practices, from controlled substances work to drug development, to Hatch-Waxman, to drug pricing, to medical device regulation. is the largest dedicated food and drug law firm in the country. Karst , Alan M. Kirschenbaum , Frank J.

article thumbnail

ACI’s Advanced Legal, Regulatory and Compliance Forum on OTC Drugs, January 23?–?24, 2024, New York, NY — Featuring HPMer and Former FDAer Deborah Livornese

The FDA Law Blog

The American Conference Institute (“ACI”) will be hosting the go-to forum for critical updates on OTC regulation and enforcement, monograph reform, ACNU and advertising essentials… and FDA Law Blog readers can get a discount. FDA Law Blog is a conference media partner for this event. Deb along with fellow panelists Kyle Y.

FDA 52
article thumbnail

New EU AI Regulation and GAMP® 5

ISPE

On 21 April 2021, the EU Commission presented the long-awaited draft on the regulation of AI. The regulation is the first targeted legal regulation of AI. The regulation is the first targeted legal regulation of AI.

article thumbnail

Medicinal cannabis: the route to good manufacturing practice registration

European Pharmaceutical Review

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API).